gilead sciences inc (GILD:NASDAQ GS)
Kevin B. Young CBE
Senior Advisor, Gilead Sciences Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2013
Mr. Kevin B. Young, CBE has been Senior Advisor of Gilead Sciences Inc. since February 4, 2014. Mr. Young served as an Executive Vice President of Commercial Operations at Gilead Sciences Inc. from September 14, 2004 to February 4, 2014. He is a Executive Vice President of Commercial Operations at Gilead Palo Alto, Inc. He served as Head of the U.S. Inflammation Business Unit and led the re-launch of Enbrel following the acquisition of Immunex. Mr. Young has an Undergraduate ...
333 Lakeside DrivePhone: 650-574-3000
Foster City, California 94404
Board Members Memberships*There is no Board Members Memberships data available.
University of Michigan
Liverpool John Moores University
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|